Navigation Links
PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
Date:7/31/2009

COLUMBUS, Ohio, July 31 /PRNewswire/ -- PharmaForce, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP, a generic version of Schering Corporation's Celestone(R) Soluspan(R).

PharmaForce's product is manufactured in the USA and is marketed in a 6 mg/mL (3 mg base betamethasone/mL; 3 mg/mL betamethasone acetate), 5mL vial dosage form.

Shipment of this product has commenced and is available through wholesalers and distributors.

"PharmaForce is proud to be providing the healthcare community with this first generic equivalent of Celestone(R) Soluspan(R)," said Nicholas Uchyn, Vice President of Sales.

About PharmaForce, Inc.

PharmaForce, Inc., founded in 1999, is a privately held specialty pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. PharmaForce specializes in injectable, ophthalmic and otic products with more than 35 FDA approved medicines as well as over 30 additional products in development.

For more information about Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension and PharmaForce, Inc., please visit: www.pharmaforceinc.com.

Please refer to www.pharmaforceinc.com for full prescribing information.

Celestone(R) Soluspan(R) is a registered trademark of Schering Corporation.

    Media Contact:
    Nicholas Uchyn
    Vice President of Sales
    PharmaForce, Inc.
    960 Crupper Avenue
    Columbus, Ohio 43229
    614/436-2222
    nuchyn@pharmaforceinc.com


'/>"/>
SOURCE PharmaForce, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caldwell College Receives Approval to Launch First Ph.D. for Applied Behavior Analysis-Autism Treatment in New Jersey
2. Pitt receives $13.4 million NIH grant to create virtual models for epidemics
3. Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom
4. TriReme Medical, Inc. Receives CE Marking for Glider(TM) PTCA Dilatation Catheter
5. New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
6. GenVec Receives Grant for Malaria Vaccine Program
7. Olympus Managed Health Care Receives Third Party Administrative License in State of Florida
8. Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award
9. Lilly Receives Award From National Medical Association
10. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
11. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... RICHEY, Fla. (PRWEB) , ... April 24, 2017 ... ... and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives of ... slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers by ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively ... it is not known to have significant interactions with antiretroviral therapy (ART). ... cholesterol levels and dampen inflammation in the bloodstream. , While lowering cholesterol and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts of ... of them to be very practical. She wanted to write a guide/workbook that would ... their health. It prompted her in writing “ A Clear Path to a Vibrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, ... Trin, and Omega Station” is the creation of published author, Chris Jackson. Chris ... where he works in the Dallas Independent School District teaching English. He is heavily ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), ... ANCD BRAIN device as the product advances towards regulatory and clinical phases. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
Breaking Medicine Technology: